AASLD 2024-话题@MedSci

#AASLD 2024#

0篇内容 | 486人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2244679, encodeId=fc4122446e960, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD2024速递】高志良教授团队：HBV感染机制探索, objectType=article, longId=856488, objectId=252585648800, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=252585648800, replyNumber=0, likeNumber=44, createdTime=2024-12-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=252585648800, moduleTitle=【AASLD2024速递】高志良教授团队：HBV感染机制探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=252585648800)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243485, encodeId=40a32243485db, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD2024速递】核苷经治停药后复发的慢乙肝患者接受聚乙二醇干扰素α治疗后的应答率优于初治患者, objectType=article, longId=855904, objectId=c1d5855904b0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401030/1730265935847_8538692.jpg, objectUrl=/article/show_article.do?id=c1d5855904b0, replyNumber=0, likeNumber=32, createdTime=2024-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=c1d5855904b0, moduleTitle=【AASLD2024速递】核苷经治停药后复发的慢乙肝患者接受聚乙二醇干扰素α治疗后的应答率优于初治患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1d5855904b0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243514, encodeId=749e2243514a5, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD 2024速递】目前血清HBV标志物不能很好反映初治HBeAg阴性慢乙肝患者肝内HBV复制活性, objectType=article, longId=851240, objectId=a0db8512400d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=a0db8512400d, replyNumber=0, likeNumber=34, createdTime=2024-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=a0db8512400d, moduleTitle=【AASLD 2024速递】目前血清HBV标志物不能很好反映初治HBeAg阴性慢乙肝患者肝内HBV复制活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0db8512400d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2242175, encodeId=901322421e5a5, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD2024速递】循环Tfh17细胞亚群在不同免疫阶段慢乙肝患者中的分布不同, objectType=article, longId=854166, objectId=f72385416654, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719481658993_92910.png, objectUrl=/article/show_article.do?id=f72385416654, replyNumber=0, likeNumber=30, createdTime=2024-12-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f72385416654, moduleTitle=【AASLD2024速递】循环Tfh17细胞亚群在不同免疫阶段慢乙肝患者中的分布不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f72385416654)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2242176, encodeId=2a3222421e65e, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD2024速递】疗效预测指标：血浆铁调素和结合珠蛋白水平, objectType=article, longId=854270, objectId=52ff8542e019, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240523/1716446115885_5579292.jpg, objectUrl=/article/show_article.do?id=52ff8542e019, replyNumber=0, likeNumber=30, createdTime=2024-12-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=52ff8542e019, moduleTitle=【AASLD2024速递】疗效预测指标：血浆铁调素和结合珠蛋白水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52ff8542e019)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2238288, encodeId=36dd223828889, content=<a href='/topic/show?id=2200854517' target=_blank style='color:#2F92EE;'>#HCC#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=2024 AASLD | T+A治疗晚期HCC：疗效预测与静脉曲张出血风险探究, objectType=article, longId=851546, objectId=2071851546ef, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241107/1730967184313_8538692.jpg, objectUrl=/article/show_article.do?id=2071851546ef, replyNumber=0, likeNumber=47, createdTime=2024-11-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=2071851546ef, moduleTitle=2024 AASLD | T+A治疗晚期HCC：疗效预测与静脉曲张出血风险探究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2071851546ef)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2233438, encodeId=cbca2233438db, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD2024速递】提高HBsAg清除持久性的策略研究, objectType=article, longId=848852, objectId=feef8488524d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401026/1729954243486_8538692.png, objectUrl=/article/show_article.do?id=feef8488524d, replyNumber=0, likeNumber=50, createdTime=2024-10-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=feef8488524d, moduleTitle=【AASLD2024速递】提高HBsAg清除持久性的策略研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feef8488524d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2232969, encodeId=073722329694c, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD2024速递】联合抗病毒治疗慢乙肝患者的疗效更佳, objectType=article, longId=847457, objectId=8ae584e45776, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=8ae584e45776, replyNumber=0, likeNumber=40, createdTime=2024-10-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8ae584e45776, moduleTitle=【AASLD2024速递】联合抗病毒治疗慢乙肝患者的疗效更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ae584e45776)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2232726, encodeId=45fa2232e2608, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a> <a href='/topic/show?id=266a10e378e5' target=_blank style='color:#2F92EE;'>#代谢相关脂肪性肝病#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle= 【AASLD2024速递】无创诊断新进展：探讨慢乙肝及合并MASLD患者的肝纤维化检测, objectType=article, longId=847942, objectId=637284e9425f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719489899523_2570354.png, objectUrl=/article/show_article.do?id=637284e9425f, replyNumber=0, likeNumber=50, createdTime=2024-10-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=637284e9425f, moduleTitle= 【AASLD2024速递】无创诊断新进展：探讨慢乙肝及合并MASLD患者的肝纤维化检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=637284e9425f)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

慢性乙型肝炎代谢相关脂肪性肝病 AASLD 2024

2024-10-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBV# #AASLD 2024#

【AASLD2024速递】高志良教授团队：HBV感染机制探索

2024-12-24发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#聚乙二醇干扰素α# #慢乙肝# #AASLD 2024#

【AASLD2024速递】核苷经治停药后复发的慢乙肝患者接受聚乙二醇干扰素α治疗后的应答率优于初治患者

2024-12-19发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #AASLD 2024#

【AASLD 2024速递】目前血清HBV标志物不能很好反映初治HBeAg阴性慢乙肝患者肝内HBV复制活性

2024-12-19发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #AASLD 2024#

【AASLD2024速递】循环Tfh17细胞亚群在不同免疫阶段慢乙肝患者中的分布不同

2024-12-13发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #AASLD 2024#

【AASLD2024速递】疗效预测指标：血浆铁调素和结合珠蛋白水平

2024-12-13发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HCC# #AASLD 2024#

2024 AASLD | T+A治疗晚期HCC：疗效预测与静脉曲张出血风险探究

2024-11-21发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #AASLD 2024#

【AASLD2024速递】提高HBsAg清除持久性的策略研究

2024-10-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #AASLD 2024#

【AASLD2024速递】联合抗病毒治疗慢乙肝患者的疗效更佳

2024-10-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性乙型肝炎# #代谢相关脂肪性肝病# #AASLD 2024#

【AASLD2024速递】无创诊断新进展：探讨慢乙肝及合并MASLD患者的肝纤维化检测

2024-10-23发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务